Back to funds
View filing
Remedium Capital Partners, LLC
hedge fundUpdated 9 days agoManaged by Remedium Capital Partners, Llc • Latest filing Q3 2026
Portfolio value
$273.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $170.2M |
| Q1 2026 | $319.8M |
| Q2 2026 | $451.6M |
| Q3 2026 | $273.6M |
Top holdings
6 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $103.3M | 1.16M | 37.77% | — | |
| 2 | $79.5M | 954.1K | 29.05% | — | |
| 3 | ? N/A Damora Therapeutics Inc | $43.5M | 2.05M | 15.91% | — |
| 4 | $25.4M | 1.81M | 9.28% | — | |
| 5 | $16.6M | 518.5K | 6.06% | — | |
| 6 | $5.3M | 361.3K | 1.93% | — |